Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ATEX
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Scott A. Lang President and CEO, Director | ATEX Anterix Inc. | Sale | 15,000 | $80.00 | $1.2M Sale | Form 4/A ↗ |
| Sep 10, 2026 | Heather Martin Chief Marketing Officer | ATEX Anterix Inc. | Sale | 8,064 | $84.20 | $679.0K Sale | Form 4 ↗ |
| Sep 10, 2026 | Leslie B. Daniels Director | ATEX Anterix Inc. | Sale | 2,500 | $83.83 | $209.6K Sale | Form 4 ↗ |
| Sep 8, 2026 | Gena L. Ashe Chief Legal Officer & Corp Sec | ATEX Anterix Inc. | Sale | 4,064 | $85.44 | $347.2K Sale | Form 4/A ↗ |
| Sep 8, 2026 | Gena L. Ashe Chief Legal Officer & Corp Sec | ATEX Anterix Inc. | Sale | 293 | $85.44 | $25.0K Sale | Form 4/A ↗ |
| Sep 4, 2026 | Leslie B. Daniels Director | ATEX Anterix Inc. | Sale | 1,200 | $86.50 | $103.8K Sale | Form 4 ↗ |
| Sep 4, 2026 | Leslie B. Daniels Director | ATEX Anterix Inc. | Sale | 2,900 | $87.31 | $253.2K Sale | Form 4 ↗ |
| Sep 3, 2026 | Leslie B. Daniels Director | ATEX Anterix Inc. | Sale | 6,000 | $87.15 | $522.9K Sale | Form 4 ↗ |
| Aug 25, 2026 | Christopher Guttman-McCabe Chief Reg & Comm Officer | ATEX Anterix Inc. | Sale | 2,696 | $90.61 | $244.3K Sale | Form 4 ↗ |
| Aug 25, 2026 | Christopher Guttman-McCabe Chief Reg & Comm Officer | ATEX Anterix Inc. | Sale | 7,580 | $91.69 | $695.0K Sale | Form 4 ↗ |
| Aug 25, 2026 | Christopher Guttman-McCabe Chief Reg & Comm Officer | ATEX Anterix Inc. | Sale | 7,791 | $92.77 | $722.8K Sale | Form 4 ↗ |
| Aug 25, 2026 | Christopher Guttman-McCabe Chief Reg & Comm Officer | ATEX Anterix Inc. | Sale | 5,372 | $93.59 | $502.8K Sale | Form 4 ↗ |
| Aug 24, 2026 | Thomas R. Kuhn Director | ATEX Anterix Inc. | Sale | 400 | $91.01 | $36.4K Sale | Form 4 ↗ |
| Aug 24, 2026 | Thomas R. Kuhn Director | ATEX Anterix Inc. | Sale | 790 | $90.00 | $71.1K Sale | Form 4 ↗ |
| Aug 24, 2026 | Thomas R. Kuhn Director | ATEX Anterix Inc. | Sale | 4,418 | $89.12 | $393.7K Sale | Form 4 ↗ |
| Aug 24, 2026 | Thomas R. Kuhn Director | ATEX Anterix Inc. | Sale | 4,392 | $88.18 | $387.3K Sale | Form 4 ↗ |
| Aug 14, 2026 | William Heard Director | ATEX Anterix Inc. | Sale | 46,400 | $90.11 | $4.2M Sale | Form 4 ↗ |
| Aug 14, 2026 | Scott A. Lang President and CEO, Director | ATEX Anterix Inc. | Sale | 5,373 | $88.96 | $478.0K Sale | Form 4 ↗ |
| Aug 14, 2026 | Scott A. Lang President and CEO, Director | ATEX Anterix Inc. | Sale | 18,797 | $90.16 | $1.7M Sale | Form 4 ↗ |
| Aug 14, 2026 | Scott A. Lang President and CEO, Director | ATEX Anterix Inc. | Sale | 10,087 | $90.87 | $916.6K Sale | Form 4 ↗ |
| Aug 14, 2026 | Scott A. Lang President and CEO, Director | ATEX Anterix Inc. | Sale | 800 | $91.69 | $73.4K Sale | Form 4 ↗ |
| Jun 18, 2026 | Scott A. Lang President and CEO, Director | ATEX Anterix Inc. | Sale | 170 | $80.25 | $13.6K Sale | Form 4 ↗ |
| Jun 18, 2026 | Thomas R. Kuhn Director | ATEX Anterix Inc. | Sale | 1,654 | $79.52 | $131.5K Sale | Form 4 ↗ |
| Jun 17, 2026 | Elena Marquez Chief Financial Officer | ATEX Anterix Inc. | Sale | 4,291 | $79.50 | $341.1K Sale | Form 4 ↗ |
| Jun 16, 2026 | Mahvash Yazdi Director | ATEX Anterix Inc. | Sale | 7,000 | $80.00 | $560.0K Sale | Form 4 ↗ |
| Jun 15, 2026 | Mark Fleischhauer Director | ATEX Anterix Inc. | Sale | 3,500 | $79.83 | $279.4K Sale | Form 4 ↗ |
| Jun 15, 2026 | Christopher Guttman-McCabe Chief Reg & Comm Officer | ATEX Anterix Inc. | Sale | 7,755 | $84.40 | $654.5K Sale | Form 4/A ↗ |
| Jun 15, 2026 | Christopher Guttman-McCabe Chief Reg & Comm Officer | ATEX Anterix Inc. | Sale | 21,050 | $83.86 | $1.8M Sale | Form 4/A ↗ |
| Jun 15, 2026 | Christopher Guttman-McCabe Chief Reg & Comm Officer | ATEX Anterix Inc. | Sale | 21,045 | $82.39 | $1.7M Sale | Form 4/A ↗ |
| Jun 15, 2026 | Christopher Guttman-McCabe Chief Reg & Comm Officer | ATEX Anterix Inc. | Sale | 34,870 | $81.51 | $2.8M Sale | Form 4/A ↗ |
| Jun 15, 2026 | Christopher Guttman-McCabe Chief Reg & Comm Officer | ATEX Anterix Inc. | Sale | 21,434 | $80.63 | $1.7M Sale | Form 4/A ↗ |
| Jun 15, 2026 | Christopher Guttman-McCabe Chief Reg & Comm Officer | ATEX Anterix Inc. | Sale | 5,030 | $79.53 | $400.0K Sale | Form 4/A ↗ |
| Jun 15, 2026 | Christopher Guttman-McCabe Chief Reg & Comm Officer | ATEX Anterix Inc. | Sale | 11,668 | $78.73 | $918.6K Sale | Form 4/A ↗ |
| Jun 15, 2026 | Gena L. Ashe Chief Legal Officer & Corp Sec | ATEX Anterix Inc. | Sale | 4,336 | $82.14 | $356.2K Sale | Form 4 ↗ |
| Jun 15, 2026 | Gena L. Ashe Chief Legal Officer & Corp Sec | ATEX Anterix Inc. | Sale | 13,375 | $81.04 | $1.1M Sale | Form 4 ↗ |
| Dec 18, 2025 | Scott A. Lang President and CEO, Director | ATEX Anterix Inc. | Buy | 1,160 | $21.61 | $25.1K Buy | Form 4 ↗ |
| Dec 8, 2025 | Scott A. Lang President and CEO, Director | ATEX Anterix Inc. | Buy | 2,450 | $20.41 | $50.0K Buy | Form 4 ↗ |
| Nov 18, 2025 | Gena L. Ashe Chief Legal Officer & Corp Sec | ATEX Anterix Inc. | Sale | 6,564 | $21.07 | $138.3K Sale | Form 4 ↗ |
| Sep 18, 2025 | Scott A. Lang President and CEO, Director | ATEX Anterix Inc. | Buy | 4,650 | $21.28 | $99.0K Buy | Form 4 ↗ |
| Aug 19, 2025 | Timothy Gray Chief Financial Officer | ATEX Anterix Inc. | Buy | 50 | $22.07 | $1,104 Buy | Form 4 ↗ |
| Mar 21, 2025 | William Heard Director | ATEX Anterix Inc. | Sale | 3,500 | $37.97 | $132.9K Sale | Form 4 ↗ |
| Mar 20, 2025 | William Heard Director | ATEX Anterix Inc. | Sale | 7,000 | $38.40 | $268.8K Sale | Form 4 ↗ |
| Mar 19, 2025 | William Heard Director | ATEX Anterix Inc. | Sale | 6,500 | $38.93 | $253.0K Sale | Form 4 ↗ |
| Mar 17, 2025 | William Heard Director | ATEX Anterix Inc. | Sale | 8,251 | $38.73 | $319.6K Sale | Form 4 ↗ |
| Feb 20, 2025 | William Heard Director | ATEX Anterix Inc. | Sale | 2,249 | $41.67 | $93.7K Sale | Form 4 ↗ |
| Feb 14, 2025 | William Heard Director | ATEX Anterix Inc. | Sale | 7,900 | $41.18 | $325.3K Sale | Form 4 ↗ |
| Dec 16, 2024 | Morgan E. Obrien Executive Chairman, Director | ATEX Anterix Inc. | Sale | 13,609 | $33.44 | $455.1K Sale | Form 4 ↗ |
| Dec 5, 2024 | Mark Fleischhauer Director | ATEX Anterix Inc. | Buy | 3,500 | $34.19 | $119.7K Buy | Form 4 ↗ |
| Nov 20, 2024 | Leslie B. Daniels Director | ATEX Anterix Inc. | Buy | 2,000 | $32.75 | $65.5K Buy | Form 4 ↗ |
| Nov 19, 2024 | Gena L. Ashe Chief Legal Officer & Corp Sec | ATEX Anterix Inc. | Sale | 5,547 | $33.00 | $183.1K Sale | Form 4 ↗ |
50 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:26 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances